CD26/DPP IV in experimental and clinical organ transplantation

Advances in Experimental Medicine and Biology

Volumn 524, Issue , 2003, Pages 133-143

  Korom, Stephan ^a,b   De Meester, Ingrid ^c   Belyaev, A ^c   Schmidbauer, Georg ^a   Schwemmle, Konrad ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; ENZYME INHIBITOR; INTERLEUKIN 2 RECEPTOR BETA; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME KINETICS; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD26; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; METALLOENDOPEPTIDASES; MODELS, ANIMAL; PHOSPHONIC ACIDS; RATS; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 0038363930     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (20)

1. Morimoto, C., and Schlossman,S. F., 1994. CD26 a key costimulatory molecule on CD4 memory cells. The Immunologist 2/1:4-7.
2. De Meester, I., Korom, S., Van Damme, J., and Scharpé, S., 1999. CD26, let it cut or cut it down. Immunology Today 20: 367-375.
3. Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S.F., Morimoto, C., 1993. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc Natl Acad Sci USA 90: 4586-4590.
4. Tanaka, T., Duke-Cohan, J. S., Kameoka, J., et al. 1994. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci USA 91: 3082-3086.
5. Scharpé, S., De Meester, I., Vanhoof, G., et al. 1990. Serum dipeptidyl peptidase IV activity in transplant recipients. Clin Chem 36:984.
6. Sanda, M.G., Pierson, R., Smith, C., and Rose, E., 1989. Serum dipeptidyl peptidase IV in cardiac transplant recipients. Transplant Proc 21:2525-2526.
7. Belyaev, A., Borloo, M., Augustyns, K., et al. 1995. A new synthetic method for proline diphenyl phosphonates. Tetrahedron Letters 36:3755-3758.
8. Lambeir, A.M., Borloo, M., De Meester, I., et. al. 1996. Dipeptidyl-derived diphenyl phosphonate esters: mechanism-based inhibitors of dipeptidyl-peptidase IV. Biochimica Biophys Acta 1290:76-82.
9. Korom, S., De Meester, I., Stadlbauer, T.H.W., et al. 1997. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 63:1495-1500.
10. Scharpé; S., De Meester, I., Vanhoof, G., Hendriks, D., van Sande, M., Van Camp, K., and Yaron, A., 1988. Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphtylamine. Clinical Chemistry 34:2299-2301.
11. Binder, J., Lehmann, M., Graser, E., Hancock, W.W., et al., 1996. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation 61:804-811.
12. Fleischer, B., 1987. A novel pathway of human T cell activation via a 103 kD T cell activationmolecule. J Immunol 138:1346-1350.
13. Dang, N.H., Hafler, D., Schlossman, S.F., and Breitmeyer, J., 1990. FcR-mediated cross-linking of Tal (CDw26) induces human T lymphocyte activation. Cell Immunol 125:42-57.
14. Dang, N.H., Torimoto, Y., Sugita, K., Daley, J.F., Schow, P., Prado, C., Schlossman, S.F., and Morimoro, C., 1990. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol 145:3963-3971.
15. Schön, E., Jahn, S., Kiessig, S.T., et al. 1987. The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 17:1821-1826.
16. Flentke, G.R., Muñoz, E., Huber, B.T., Plaut, A.G., Kettner, C.A., and Bachovchin, W., 1991. Inhibition of dipeptidyl peptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. Proc Natl Acad Sci USA 88:1556-1559.
17. Kubota, T., Iizuka, H., Bachovchin, W.W., and Stollar, B.D., 1994. Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL/Mp-1pr/1pr mice correlates with disease onset. Clin Exp Immunol 96:292-296.
18. Bednarczyk, J., Caroll, S.M., Marin, C., and McIntyre, B., 1991. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation. J Cell Biochem 46:206-218.
19. Korom, S., De Meester, I., Schmidbauer, G., et al. 1999. Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity. Transplant Proceedings, 31: 873.
20. Korom, S., De Meester, I., Maas, E., et al., 2002. CD26 expression and enzymatic activity in recipients of kidney allografts. Transplant Proceedings, 34: 1753-1754.